Zusammenfassung
Die Glukosetoleranz eines gesunden Menschen wird von vielen Faktoren bestimmt. Unter anderen modifizieren der Fett- und Muskelanteil am Körpergewicht und das Ausmaß der körperlichen Aktivität die Fähigkeit des Organismus, über eine Kohlenhydratbelastung zu disponieren. Der mit dem Lebensalter zunehmende Nüchternblutzucker gibt den ersten Hinweis für den möglichen Einfluß des Alters auf die Kohlehydrattoleranz (Spence 1920).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Abbasi F, Carantonie M, Kamath V, Chen Y-DI, Rizvi AA, Reaven GM (1997) Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylureatreated patients. Diabetes Care 20: 1863–1869
Aiello LP, Bursell SE, Clermont A, Duh E, Ishii H, Takagi C, Mori F, Ciulla TA, Ways K, Jirousek M, Smith LE, King GL (1997) Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46: 1473–1480
Akasaka T, Yoshida K, Hozumi T, Takagie G, Kaji S, Kawamoto T, Morioka S, Yoshikawa J (1997) Retinopathy identifies marked restriction of coronary blood flow reserve in patients with diabetes mellitus. J Am Coll Cardiol 30: 935–941
Alberti KG, Johnson AB, Taylor R (1992) Gliclazide: metabolic and vascular effects — a perspective. Metabolism 41: 40–45
Antonucci T, McLain R, Whitcomb R, Lockwood D (1997) Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglizazone. Diabetes Care 20: 188–193
Arieff AI, Caroll HJ (1972) Nonketotic hyperosmolar coma with hyperglycemia: clinical features, pathophysiology, renal function, acid-base balance, plasma-cerebrospinal fluid equilibrium and the effects of therapy in 37 cases. Medicine 51: 73–94
Aronson D, Rayfield EJ, Chesebro JH (1997) Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 126: 296–306
BARI Investigators (1997) Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. Circulation 96: 1761–1769
Bennett PH (1984) Diabetes in the elderly: diagnosis and epidemiology. Geriatrics 39/5: 37–41
Berger M, Baumhoff E, Gries FA (1976) Gewichtsreduktion und Glukose-Intoleranz bei Adipositas. Dtsch Wochenschr 101: 307–311
Berger W, Sonnenberg GE (1980) Blutzuckertagesprofile und Hämoglobin A1 bw. A1c zur Überwachung der Diabetesbehandlung. Schweiz Med Wochenschr 110: 485–491
Bernbaum M, Albert SG, McGinnis J, Brusca S, Mooradian AD (1994) The reliability of self blood glucose monitoring in elderly diabetic patients. J Am Geriatr Soc 42: 779–781
Bijlstra PJ, Lutterman JA, Russel FGM, Thien T, Smits P (1996) Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans. Diabetologia 39: 1083–1090
Blunt BA, Barrett-Connor E, Wingard DL (1991) Evaluation of fasting plasma glucose as screening test for NIIDM in older adults. Rancho Bernardo Study. Diabetes Care 14: 989–993
Bolinder J, Östmann J, Arner P (1983) Influence of aging on insulin receptor binding and metabolic effects of insulin on human adipose tissue. Diabetes 32: 959–964
Braunwald E (1997) Shattuck Lecture — cardiovascular medicine at the turn of the millenium: triumphs, concerns, and opportunities. N Engl J Med 337: 1360–1369
Bretzel RG (1997) Effects of antihypertensive drugs on renal function in patients with diabetic nephropathy. Am J Hypertension 10: 208S–217S
Cacciatori V, Dellera A, Bellavere F, Bongiovanni LG, Teatini F, Gemma ML, Muggeo M (1997) Comparative assessment of peripheral sympathetic function by postural vasoconstriction ateriolar reflex and sympathetic skin response in NIDDM patients. Am J Med 102: 365–370
Cahill GF, McDevitt HO (1981) Insulin-dependent diabetes mellitus: the initial lesions. N Engl J Med 304: 1454–1465
Cameron NE, Cotter MA (1997) Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 46 [Suppl 2]: S31–S37
Chantelau E, Spraul M (1986) Der diabetische Fuß. Internist Welt 7: 230–236
Cleveland JC, Melrum DR, Cain BS, Banerjee A, Harken AH (1997) Oral sulfonylurea hypoglycemic agents prevent ischemie preconditioning in human myocardium. Circulation 96: 29–32
Cortis M-C, Guralnik JM, Salive ME, Harris T, Ferrucci L, Glynn RJ, Havlik RJ (1997) Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 126: 753–760
DeFronzo RA (1979) Glucose intolerance and aging. Diabetes 28: 1095–1101
DeFronzo RA (1997) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity hypertension, dyslipidemia and atherosclerosis. Neth J Med 50: 191–197
Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986
Dudl RJ, Ensinck JW (1977) Insulin and glucagon relationship during aging in man. Metabolism 26: 33–41
Eastman RC, Keen H (1997) The impact of cardiovascular disease on people with diabetes: the potential for prevention. Lancet 350 [Suppl 1]: 29–32
Edmonds ME, Roberts VC, Watkins PJ (1982) Blood flow in the diabetic neuropathic foot. Diabetologia 22: 9–15
Egger ThP, Tragi KH, Schernthaner G, Prager R (1985) Glukosetoleranz und Alter: Untersuchungen der Insulinsekretion, der Insulinrezeptorbindung und in vivo Insulinsensitivität. Klin Wochenschr 63 [Suppl 4]: 80
Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Rosenfield RL, Polonsky KS (1997) Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metabol 82: 2108–2116
Eliason M, Jansson JH, Nilsson P, Asplund K (1997) Increased levels of tissue Plasminogen activator antigen in essential hypertension. A population-based study in Sweden. J Hypertens 15: 349–356
Esposito C, Gerlach H, Brett J, Stern H, Vlassara H (1989) Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170: 1387–1407
Expert Committee on the Diagnosis and Classification of Diabetes mellitus (1997) Report. Diabetes Care 20: 1183–1197
Feinglos MN, Bethel MA, Thacker CH, Lane JD, English J (1997) Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with typ-2-diabetes. Diabetes Care 20: 1539–1542
French LR, Goetz FC, Martinez AM, Boen JR, Bushhouse SA, Sprafka JM (1992) Association between stimulated plasma C-peptide and age: the Wadena city health study. J Am Geriatr Soc 40: 309–315
Gale EAM, Dornan TL, Tattersall RB (1981) Severely uncontrolled diabetes in the over fifties. Diabetologia 21: 25–28
Gall M-A, Hougaard P, Borch-Johnson K, Parving H-H (1997) Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. Br Med J 314: 783–788
Gilde JL, Hendryx M, Casia C, Singh SP (1989) The effectivenes of diabetes education programs for older patients and their spouses. J Am Geriatr Soc 37: 1023–1030
Gradman TJ, Laws A, Thompson LW, Reaven GM (1993) Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 41: 1305–1312
Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson J (1990) Cardiovascular risk factors in confirmed prediabetic individuals. J Am Med Assoc 263: 2893–2898
Haffner SM, Miettinen H (1997) Insulin resistance implications for type II diabetes mellitus and coronary heart disease. Am J Med 103: 152–162
Hall JE (1997) Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens 10: 49S–55S
Hanssen KF (1997) Blood glucose and microvascular and macrovascular complications in diabetes. Diabetes 46 [Suppl 2]: S101–S103
Harris MI, Hadden WC, Knower WC, Bennett PH (1987) Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20–74 yr. Diabetes 36: 523–534
Hashimoto Y, Futamura A, Ikushima M (1995) Effect of aging on HbA1c in a working male Japanese population. Diabetes Care 18: 1337–1340
Hebert PR, Gaziano JM, Chan KS, Hennekens CH (1997) Cholesterol lowering with statin drugs, risk of stroke, and total mortality. J Am Med Assoc 278: 313–321
Heine RJ (1996) Role of sulfonylureas in noninsulin-dependent diabetes mellitus: part II — „the cons“. Horm Metab Res 28: 522–526
Hellman R, Regan J, Rosen H (1997) Effect of intensive treatment of diabetes on the risk of death or renal failure in NIDDM and IDDM. Diabetes Care 20: 258–264
Heimlich SP, Ragland DR, Leung RW, Paffenbarger RS (1991) Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325: 147–152
Holleman F, Hoekstra JBL (1997) Insulin Lispro. N Engl J Med 337: 176–183
Hollenbeck C, Reaven GM (1987) Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 64: 1169–1173
ISIS-2 Collaborative Group (1988) Randomised trial of intravenous Streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction. Lancet ii: 349–360
Janssens J, Peeters TL, Vantrappen G, Tack J, Urbain JL, DeRoo M, Muls F. Boullon R (1990) Improvement of gastric emptying in diabetic gastroparesis by erythromycin. N Engl J Med 322: 1028–1031
Johnson AB, Webster JM, Sum C-F (1993) The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight typ II diabetic patients. Metabolism 42: 1217–1222
Johnson KC, Graney MJ, Applegate WB, Kitabchi AE, Runyan JW, Shorr RI (1997) Prevalence of undiagnosed non-insulin-dependent diabetes mellitus and impaired glucose tolerance in a cohort of older persons with hypertension. J Am Geriatr Soc 45: 695–700
Julian-Vague I, Alessi MC (1997) PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost 78: 656–660
Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes on congestive heart failure: the Framingham Study. Am J Cardiol 34: 29–34
Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. J Am Med Assoc 241: 2035–2038
Klein R, Klein BFK, Moss SE, Cruickshanks KJ (1994) Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 154: 2169–2178
Klein R, Klein BEK, Moss SE (1996) Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 124: 90–96
Kleinberger G (1985) Therapie der schweren diabetischen Stoffwechselentgleisung (Coma diabeticum). Wien Med Wochenschr 135: 159–170
Kotsanos JG, Marrero D, Vignati L, Mathias SD, Huster W, Patrick D, Andrejasich C, Zalani S, Boggs MB, Anderson J, Jacobson AM (1997) Health-related quality-of-life results from multinational clinical trials of insulin lispro. Diabetes Care 20: 948–958
Krendel DA, Costigan DA, Hopkins LC (1995) Successful treatment of neuropathies in patiens with diabetes mellitus. Arch Neurol 52: 1053–1061
Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH (1995) Glycosylated hemoglobin and the risk of mikroalbuminuria in patients wih insulin-dependent diabetes mellitus. N Engl J Med 332: 1251–1255
Kumar S, Durrington PN, Bhatnagar D, Laing I (1994) Suppression of non-etsreified fatty acids to treat type a Insulin resistance syndrome. Lancet 343: 1073–1074
Lehmann ED, Riley WA, Clarkson P, Gosling RG (1997) Non-invasive assessment of cardiovascular disease in diabetes mellitus. Lancet 350 [Suppl 1]: 14–19
Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-convertingenzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456–1462
Lippert J, Ritz E, Schwarzbeck A, Schneider P (1995) The rising tide of end-stage renal failure from diabetic nephropathy type II — an epidemiological analysis. Nephral Dial Transplant 10: 462–467
LoGerfo FW, Coffman JD (1984) Vascular and mikrovascular disease of the foot in diabetic implications for foot care. N Engl J Med 311: 1615–1619
Lunt H (1996) Diabetes mellitus in older patients. Is tight blood glucose control warranted? Drugs Aging 8: 401–407
Lyons TJ (1992) Lipoprotein glycation and its metabolic consequences. Diabetes 41 [Suppl 2]: 67–73
Malhotra A, Sanghi V (1997) Regulation of contractile proteins in diabetic heart. Cardiovasc Res 34: 34–40
Malik RA (1997) The pathology of human diabetic neuropathy. Diabetes 46 [Suppl 2]: S50–S53
Malone ML, Gennis V, Goodwin JS (1992) Characterization of diabetic ketoacidosis in older versus younger adults. J Am Geriatr Soc 40: 1100–1104
Mathiesen ER, Hommel E, Giese J, Parving H-H (1991) Efficacy of Captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. Br Med J 303: 81–87
Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R (1992) Effects of desipramine, amitrityline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326: 1250–1256
Meigs JB, Singer DE, Sullivan LM, Dukes KA, De Agostino RB, Nathan DM, Wagner EH, Kaplan SH, Greenfield S (1997) Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): the NIDDM patient outcomes research team. Am J Med 102: 38–47
Messerli FH, Grossman E, Michalewicz L (1997) Combination therapy and target organ protection in hypertension and diabetes mellitus. Am J Hypertension 10: 198S–201S
Monnier LH, Blotman MJ, Colette C, Monnier MP, Mirouze J (1981) Effects of dietary fibre supplementation in stable and labile insulin-dependent diabetes. Diabetologia 20: 12–17
Monnier VM, Glomb M, Elgawish A, Sell DR (1996) The mechanism of collagen cross-linking in diabetes: a puzzle nearing resolution. Diabetes 45 [Suppl 3]: S67–S72
Morishita E, Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Yamazaki M, Aoshima K, Hashimoto T, Matsuda T (1996) Hypercoagulability and high lipoprotein (a) levels in patients with type II diabetes mellitus. Atherosclerosis 120: 7–14
Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H (1990) A prospective study of mortality among middle-aged, diabetic patients (the London cohort of the WHO Multinational Study of vascular disease in diabetics) I: causes and death rates. Diabetologia 33: 538–541
Mueller MJ, Strube MJ, Allen BT (1997) Therapeutic footwear can reduce plantar pressures in patients with diabetes and transmetatarsal amputation. Diabetes Care 20: 637–641
Muller DC, Elahi D, Tobin JD, Andres R (1996) The effect of age on insulin resistance and secretion: a review. Semin Nephral 16: 289–298
Nagi, DK, Yudkin JS (1993) Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and Plasminogen activator inhibitor in NIDDM sujects: a study of two ethnic groups. Diabetes Care 16: 621–629
Naliboff BD, Gilmore SL, Rosenthal MJ (1993) Acute autonomic responses to postural change, Valsalva maneuver, and paced breathing in older typ II diabetic men. J Am Geriatr Soc 41: 648–653
Nathan DM, Singer DE, Godine JE, Harrington CH, Perlmuter LC (1986) Retinopathy in older type II diabetics: association with glucose control. Diabetes 35: 797–801
Nathan DM (1993) Long-term complications of diabetes mellitus. N Engl J Med 328: 1676–1685
Nathan DM (1996) The pathophysiology of diabetic complications: how much does the glucose hypothesis explain? Ann Intern Med 124 (1 pt 2):86–89
National Diabetes Data Group (NDDG) (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057
Nichols CG, Ripoll C, Lederer WJ (1991) ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction. Circ Res 68: 280–287
Nielsen FS, Rossing P, Gall M-A, Smidt UM, Chen JW, Sato A, Parving H-H (1997) Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy. Scand J Clin Lab Invest 57: 427–434
Nolan JJ, Freidenberg G, Henry R, Reichart D, Olefsky JM (1994) Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of NIDDM and obesity. J Clin Endocrinol Metab 78: 471–477
Oki JC (1995) Dyslipidaemia in patients with diabetes mellitus: classification and risks and benefits of therapy. Pharmacotherapy 15: 317–337
Oskarsson P, Ljunggren JG, Lins PE (1997) Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group. Diabetes Care 20: 1594–1597
Osterby R, Gall M-A, Schmitz A, Nielsen FS, Nyberg G, Parving H-H (1993) Glomerular structure and function in Proteinurie type-2 (non-insulin-dependent) diabetic patients. Diabetologia 36: 1064–1070
Paillole C, Dahan M, Paycha F, Solal AC, Passa P, Gourgon R (1989) Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type I (Insulin dependent) diabetic patients. Am J Cardiol 64: 1010–1016
Panzram G (1973) Epidemiologie des Coma diabeticum. Schweiz Med Wochenschr 103: 203–208
Panzram G, Zabel-Langhennig R (1981) Prognosis of diabetes mellitus in a geographically defined population. Diabetologia 20: 587–591
Paton RC (1981) Haemostatic changes in diabetic coma. Diabetologia 21: 172–177
Pfeifer MA, Schumer MP, Gelber DA (1997) Aldose reductase inhibitors: the end for an era or the need for differential trial designs? Diabetes 46 [Suppl 2]: S82–S89
Pfeiffer A, Spranger J, Meyer-Schwickerath R, Schatz H (1997) Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown. Diabetes 46 [Suppl 2]: S26–S30
Piatti PM, Monti LD, Davis SN, Conti M, Brown MD, Pozza G, Alberti KGMM (1996) Effects of an acute decrease in non-esterified fatty acid levels in muscle glucose utilisation and forearm indirect calorimetry in lean NIDDM patients. Diabetologia 39: 103–112
Prachar H, Bruneder H, Nobis H, Korp W (1975) Coma diabeticum. Bericht über 752 Fälle (1931 bis 1973). Münch Med Wochenschr 117: 661–668
Pugh JA, Medina E, Ramirez M (1993) Comparison of the course to end-stage renal disease of type-1-(insulin-dependent) and type-2-(noninsulin-dependent) diabetic nephropathy. Diabetologia 36: 1094–1098
Pyörälä K, Olsson AG, Pedersen TR, Thorgeirsson G, Kjekshus J, Faergeman O (1997) Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care 20: 614–620
Randle P, Hales CN, Garland PB, Newsholme EA (1963) The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i: 785–789
Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H (1982) Infection and diabetes: the case for glucose control. Am J Med 72: 439–450
Reaven GM (1985) Beneficial effect of moderate weight loss in older patients with non-insulindependent diabetes mellitus poorly controlled with insulin. J Am Geriatr Soc 33: 93–95
Reaven GM (1988) Banting lecture. Role of insulin resistance in human disease. Diabetes 37: 1595–1607
Rimoin DL, Rotter JI (1984) The genetics of diabetes mellitus. In: Andreani D, Federlin KF, DiMario U, Heding LG (eds) Immunology in diabetes. Klimpton, London, p 63
Rizza RA, Mandarino LJ, Genest J, Baker BA, Gerich JE (1985) Production of insulin resistance by hyperinsulinaemia in man. Diabetologia 28: 70–75
Roßkamp R, Wernicke-Panten K, Draeger E (1996) Clinical profile of the novel sulphonylurea glimepiride. Diab Res Clin Pract 31 [Suppl]: S33–S42
Said G, Goulon-Goeau C, Lacroix C, Moulonguet A (1994) Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 35: 559–569
Sandouk T, Reda D, Hofmann C (1993) The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger-RNA-transcript stability. Endocrinology 133: 352–359
Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the SSS-Study. Lancet 344: 1383–1389
Schernthaner H (1985) Ätiologie und Pathogenese des Syndroms Diabetes mellitus. Wien Med Wochenschr 135: 139–145
Schöffling K, Hillebrand I (1981) Acarbose — ein neues therapeutisches Prinzip in der Behandlung des Diabetes mellitus. Dtsch Med Wochenschr 106: 1083–1084
Segal P, Rybka J, Feig PU, Petzinna D, Schernthaner G, Berlin C, Ratzmann KP (1997) The efficacy and safety of miglitol therapy compared with gliben-clamide in patients with NIDDM inadequately controlled by diet alone. Diabetes Care 20: 687–691
SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the SHEP. J Am Med Assoc 265: 3255–3264
Shimizu M, Kato N, Kawazu S, Ishii C, Tomono S, Ito Y, Ohno T, Murata K, Utsugi T (1996) Agerelated alteration of pancreatic beta-cell function. Diabetes Care 19: 8–11
Shorr RI, Ray WA, Daugherty JR, Griffin MR (1996) Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc 44: 751–755
Siegel RD, Cupples A, Schaefer EJ, Wilson PW (1996) Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study. Metabolism 45: 1267–1272
Singer DE, Moulton AW, Nathan DM (1989) Diabetic myocardial infarction: interaction of diabetes with other preinfarction risk factors. Diabetes 38: 350–357
Simonson DC, De Fronzo RA (1983) Glucagon physiology and aging: evidence for enhanced hepatic sensitivity. Diabetologia 25: 1–7
Sirtori C, Fraceschini G, Galli-Kienle M, Cighetti G, Galli G, Bondioli A, Conti F (1978) Disposition of metformin (NN-dimethylbiguanide) in man. Clin Pharmacol Ther 24: 683–693
Skyler JS, Beatty CM, Goldberg RB (1984) Managing diabetes: an updated look at diet. Geriatrics 39/7: 57–68
de Sonnavile JJ, Colly LP, Wijkel D, Heine RJ (1997) The prevalance and determinants of foot ulceration in type II diabetic patients in a primary health care setting. Diab Res Clin Pract 35: 149–156
Spallone V, Menzinger G (1997) Diagnosis of cardiovascular autonomic neuropathy in diabetes. Diabetes 46 [Suppl 2]: S67–S76
Spence JC (1920/21) Some observations on sugar tolerance, with special reference to variations found at different ages. Quart J Med 14: 314–326
Stewart J, Collier A, Patrick AW, Clarke BF, Weir DM (1991) Alterations in monocyte receptor function in type I diabetic patients with ketoacidosis. Diabet Med 8: 213–216
Stolk RP, Pols HAP, Lamberts SWJ, Dejong PTVM, Hofman A, Grobee DE (1997) Diabetes mellitus, impaired glucose tolerance, and hyperinsulinemia in an elderly population. Am J Epidemiol 145: 24–32
Strauer BE, Motz W, Vogt M, Schwartzkopff B (1997) Impaired coronary flow reserve in NIDDM: a possible role for diabetic cardiopathy in humans. Diabetes 46 [Suppl 2]: S119–S124
Straumann M, Staffelbach O, Sonnenberg GE, Keller U, Berger W (1979) Vor-und Nachteile der Insulintherapie bei älteren Diabetikern mit asymptomatischer Hyperglykämie. Schweiz Med Wochenschr 109: 1816–1820
Tater D, Tepaut B, Bercovici JP, Youinou P (1987) Polymorphonuclear cell derangements in type I diabetes. Horm Metab Res 19: 642–647
Teuscher A (1986) Die Kohlenhydrate und Nahrungsfasern in der Diabetesdiät. Schweiz Med Wochenschr 116: 282–287
The Expert Commitee on the Diagnosis and Classification of Diabetes mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20: 1183–1197
Tobey TA, Greenfield M, Kraemer F, Reaven GM (1981) Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30: 165–171
Tragi KH, Schernthaner G, Udvardi G, Kaiser F, Hupka J, Geyer G (1981) Einfluß des Alters auf Glukosetoleranz und Insulinsekretion. Akt Gerontol 11: 114–118
Tragi KH (1983) Risikofaktoren und atherosklerotische Komplikationen in Wien: Herzinfarkt und Schlaganfall. Acta Med Austriaca 10: 1–10
Uusitupa M, Mustonen J, Laakso M, Vainio P, Länsimies E, Talwar S, Pyörälä K (1988) Impairement of diastolic function in middle-aged type-1 (insulin-dependent) and type-2 (noninsulin-dependent) diabetic patients free of cardiovascular disease. Diabetologia 31: 783–791
Van Horn L (1997) Fiber, lipids, and coroary heart disease. Circulation 95: 2701–2704
Vijan S, Hofer TP, Hyward RA (1997) Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 127: 788–795
Vlassara H, Bucala R, Striker L (1994) Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70: 138–151
Waldhäusl W, Freyler H, Bratusch-Marrain P, Vierhapper H, Bruneder H (1983) Kontinuierliche subkutane Insulininfusion. Dtsch Med Wochenschr 108: 570–577
Waldhäusl W, Czerwenka-Howorka K (1985) Moderne Insulintherapie. Wien Med Wochenschr 135: 151–159
Walinder O, Wibell L, Boström H (1980) The clinical value of HbAlc-determination. Acta Med Scand [Suppl] 639: 17–22
Winocour PD (1992) Platelet abnormalities in diabetes mellitus. Diabetes 41 [Suppl 2]: 26–31
Wisotzky J, Sommer M, Schubert K, Stein G (1996) Die Akkumulation von AGE im Alterungsprozeß, bei Diabetes mellitus und bei der chronischen Niereninsuffizienz. Med Klinik 91: 454–457
Yeap BB, Wittert GA, Russo A, Horowitz M, Fraser RJ (1996) Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects. Diabetes Care 19: 880–882
Zander E, Heinke P, Gottschling D, Zander G, Strese J, Herfurth S, Michaelis D (1997) Increased prevalence of elevazed urinary albumin excretion rate in type 2 diabetic patients suffering from ischemic foot lesions. Exp Clin Endocrinol Diab 105 [Suppl 2]: 51–53
Zarich SW, Nesto RW (1989) Diabetic cardiomyopathy. Am Heart J 118: 1000–1012
Zhuang HX, Wuarin L, Fei ZJ, Ishii DN (1997) Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy. J Pharmacol Exp Ther 283: 366–374
Ziegler D, Wiefels K, Dannehl K, Gries FA (1988) Effects of one year of near-normoglycemia on peripheral nerve function in type-1 (insulindependent) diabetic patients. Klin Wochenschr 66: 388–396
Zimmet PZ, Alberti KGMM (1997) The changing face of macrovascular disease in non-insulindependent diabetes mellitus: an epidemic in progress. Lancet 350 [Suppl 1]: 1–4
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Wien
About this chapter
Cite this chapter
Tragl, K.H. (1999). Glukosetoleranz und Diabetes mellitus im Alter. In: Handbuch der Internistischen Geriatrie. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6409-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6409-9_11
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7317-6
Online ISBN: 978-3-7091-6409-9
eBook Packages: Springer Book Archive